The Rock wrestles diabetes in Novo awareness effort

Share this article:
The Rock wrestles diabetes in Novo awareness effort
The Rock wrestles diabetes in Novo awareness effort
Novo Nordisk has enlisted action film star and ex-wrestler Dwayne “The Rock” Johnson as the latest celebrity face of its Diabetes Aware campaign with the Entertainment Industry Foundation.

Johnson appears in a print PSA urging families to “Get outside. Play a game. Do something active together.” The PSA boasts the headline: “An active family is a diabetes aware family.”

Johnson said in a release: “I want to encourage families to be active and eat right. Small steps can go a long way in managing diabetes, its complications and raising healthy, active children.”

Past celebrity associations with the campaign include Halle Berry, Cuba Gooding, Jr., Dustin Hoffman, Kevin Kline and Jon Lovitz. The unbranded effort, which launched in 2004, aims to reach the 24 million Americans living with diabetes as well as the estimated 6.2 million Americans unaware that they have the disease, emphasizing the importance of detection, monitoring and proper management of diabetes.


Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...